Literature DB >> 9688608

PKC activity modulates availability and long openings of L-type Ca2+ channels in A7r5 cells.

C A Obejero-Paz1, M Auslender, A Scarpa.   

Abstract

The possibility that protein kinase C (PKC) could control the activity of L-type Ca2+ channels in A7r5 vascular smooth muscle-derived cells in the absence of agonist stimulation was investigated using the patch-clamp technique. Consistent with the possibility that L-type Ca2+ channels are maximally phosphorylated by PKC under these conditions, we show that 1) activation of PKC with the phorbol ester phorbol 12,13-dibutyrate was ineffective in modulating whole cell and single-channel currents, 2) inhibition of PKC activity with staurosporine or chelerythrine inhibited channel activity, 3) inhibition of protein phosphatases by intracellular dialysis of okadaic acid did not affect whole cell currents, and 4) the inhibitory effect of staurosporine was absent in the presence of okadaic acid. The inhibition of Ca2+ currents by PKC inhibitors was due to a decrease in channel availability and long open events, whereas the voltage dependence of the open probability and the single-channel conductance were not affected. The evidence suggests that in resting, nonstimulated A7r5 cells there is a high level of PKC activity that modulates the gating of L-type Ca2+ channels.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9688608     DOI: 10.1152/ajpcell.1998.275.2.C535

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  12 in total

1.  The involvement of intracellular Ca(2+) in 5-HT(1B/1D) receptor-mediated contraction of the rabbit isolated renal artery.

Authors:  P B Hill; K A Dora; A D Hughes; C J Garland
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

Review 2.  Pharmacology of signaling induced by dopamine D(1)-like receptor activation.

Authors:  Ashiwel S Undieh
Journal:  Pharmacol Ther       Date:  2010-06-12       Impact factor: 12.310

3.  Statistical evaluation of ion-channel gating models based on distributions of log-likelihood ratios.

Authors:  László Csanády
Journal:  Biophys J       Date:  2006-02-03       Impact factor: 4.033

4.  Kinase-dependent activation of voltage-gated Ca2+ channels by ET-1 in pulmonary arterial myocytes during chronic hypoxia.

Authors:  Trevor Luke; Julie Maylor; Clark Undem; J T Sylvester; Larissa A Shimoda
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-03-02       Impact factor: 5.464

5.  Ca2+ signalling in rat vascular smooth muscle cells: a role for protein kinase C at physiological vasoconstrictor concentrations of vasopressin.

Authors:  J Fan; K L Byron
Journal:  J Physiol       Date:  2000-05-01       Impact factor: 5.182

6.  Lysophosphatidylcholine Increases Ca Current via Activation of Protein Kinase C in Rabbit Portal Vein Smooth Muscle Cells.

Authors:  Seungsoo Jung; Youngho Lee; Sungsik Han; Youngwhan Kim; Taiksang Nam; Ducksun Ahn
Journal:  Korean J Physiol Pharmacol       Date:  2008-02-28       Impact factor: 2.016

7.  Stimulation of L-type Ca2+ channels by inositol pentakis- and hexakisphosphates in rat vascular smooth muscle cells.

Authors:  J F Quignard; L Rakotoarisoa; J Mironneau; C Mironneau
Journal:  J Physiol       Date:  2003-04-25       Impact factor: 5.182

8.  Alpha 1-adrenoceptor effects mediated by protein kinase C alpha in human cultured prostatic stromal cells.

Authors:  A Preston; J M Haynes
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

9.  Nicotinic acetylcholine receptor mediates nicotine-induced actin cytoskeletal remodeling and extracellular matrix degradation by vascular smooth muscle cells.

Authors:  Zhizhan Gu; Vera Fonseca; Chi-Ming Hai
Journal:  Vascul Pharmacol       Date:  2012-08-23       Impact factor: 5.773

10.  PKC independent inhibition of voltage gated calcium channels by volatile anesthetics in freshly isolated vascular myocytes from the aorta.

Authors:  Mohammed Fanchaouy; Luis Cubano; Hector Maldonado; Rostislav Bychkov
Journal:  Cell Calcium       Date:  2013-08-13       Impact factor: 6.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.